MARKET

RGMP

RGMP

Regnum
EXMKT
0.0059
NaN%
Closed 09:30 02/11 EST
OPEN
--
PREV CLOSE
0.0059
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.0059
52 WEEK LOW
0.0059
MARKET CAP
135.41K
P/E (TTM)
-0.1947
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at RGMP last week (0908-0912)?
Weekly Report · 09/15/2025 10:41
Weekly Report: what happened at RGMP last week (0901-0905)?
Weekly Report · 09/08/2025 10:43
Weekly Report: what happened at RGMP last week (0825-0829)?
Weekly Report · 09/01/2025 10:39
Weekly Report: what happened at RGMP last week (0818-0822)?
Weekly Report · 08/25/2025 10:47
Weekly Report: what happened at RGMP last week (0811-0815)?
Weekly Report · 08/18/2025 10:42
Weekly Report: what happened at RGMP last week (0804-0808)?
Weekly Report · 08/11/2025 10:47
Weekly Report: what happened at RGMP last week (0728-0801)?
Weekly Report · 08/04/2025 10:49
Weekly Report: what happened at RGMP last week (0721-0725)?
Weekly Report · 07/28/2025 10:50
More
About RGMP
Regnum Corp. is focused on developing and commercializing therapeutics that treat rare and infectious diseases, specifically in populations that are neglected or face adherence challenges due to inconvenient dosing or delivery system, tolerability, or cost and accessibility of available therapeutic options. The Company's primary asset is the commercial rights to leronlimab (PRO 140) in all human immunodeficiency virus (HIV) indications within the United States. Leronlimab is a monoclonal antibody. The target of leronlimab is the immunologic receptor CCR5. Leronlimab prevents certain strains of HIV from using the CCR5 receptor as an entry gateway for healthy cells. The leronlimab antibody belongs to a class of HIV therapies known as entry inhibitors that block HIV from entering into and infecting certain cells. Leronlimab blocks HIV from entering a cell by binding to a molecule called CCR5 referred to as R5 strains, attach as part of HIVs entry into a cell.

Webull offers Regnum Corp stock information, including EXMKT: RGMP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RGMP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RGMP stock methods without spending real money on the virtual paper trading platform.